Our α-Klotho Story
α-Klotho
Our Key Platform Technology
A new era has arrived, whereby Klotho Neuroscience’s platform technology can introduce the genetic material directly into human cells in the body, and the patient then becomes the “factory” for protein production inside their body. This approach is called gene therapy.
Klotho Neurosciences licensed exclusive rights to develop and commercialize a key product platform technology – a human gene and protein therapy utilizing an important gene referred to as α-Klotho.
α-Klotho was named after the Greek goddess Klotho (or Clotho), the regulator of life and aging. Thus, α-Klotho is referred to as the “anti-aging” gene and protein because there is striking evidence of α-Klotho inhibiting or reversing age-related pathologies. This includes inhibiting or stopping memory loss, cognition, and other manifestations of dementia, as well as affecting neuromuscular diseases, arteriosclerosis, osteoporosis, dermal (skin) aging, sarcopenia (muscle wasting), kidney function, and certain cancers.
Our Pipeline
Developing Life-Extending
Cell and Gene Therapies